B12 supplementation is particularly relevant because GLP-1 agonists can reduce B12 absorption over time
Available 15 mg/.5 mL 2 recent reports Shortage resolved according to the FDA but we're receiving reports of supply issues
Toxic endophyte-infected tall fescue and range grasses: historic perspectives
Two years after semaglutide cessation, 18 women had normal glucose tolerance, 3 had impaired fasting glucose, 3 had impaired glucose tolerance, and 1 developed type 2 diabetes
The goal is progressive resistance, not punishment
A new, federally funded retrospective study led by Johns Hopkins Medicine strongly suggests that semaglutide and other GLP-1 RAs did not statistically change the risk of developing neovascular age-related macular degeneration (NVAMD)-a fast-progressing, blinding condition that is caused by uncontrolled, abnormal blood vessel growth in the back of the eye-in adults with type 2 diabetes without a prior history of GLP-1 use